The Premier Consulting Blog

MAY 4, 2023

billion in 2022 and is expected to grow approximately eight percent from 2023 to 2030 [1]. The new guidance provides detailed information to applicants and manufacturers regarding compliance with the requirements in 21 CFR Part 4 for ophthalmic drugs packaged with eye cups, eye droppers, or other dispensers.

FDA 52

FDA Packaging Compliance Regulations 52

PPD

OCTOBER 18, 2023

Continued expansion of the biotech industry is occurring in parallel, with an estimated compound annual growth rate of 13.96% from 2023-2030. There has been an unprecedented expansion of different types of pharmaceutical therapies, as well as a change in the overall approach to health care.

Laboratories 52

Laboratories Assay Development Small Molecule Packaging 52

The Pharma Data

NOVEMBER 2, 2020

Setting sights on 2030. Despite setbacks due to COVID-19, WHO will accelerate work to achieve this target by 2030. The recommended essential package of care for managing lymphoedema and hydrocele should be available in 100% of districts where people are living with these manifestations.

Packaging 52

Packaging Disease Treatment Drugs 52

Agency IQ

NOVEMBER 20, 2023

readability of package leaflet, patient engagement). Summary of Product Characteristics and Package Leaflet), recommending that sponsors and regulators “explore the use of electronic media” to provide product information “in the future”. The report recognized the potential for an electronic format for Product Information (i.e.,

Production 40

Production Packaging Hospitals Regulations 40

Agency IQ

FEBRUARY 23, 2024

NANCY SKINNER has updated a bill she introduced in early January 2024 to ban the sale of intentionally added PFAS in the state after 2030. In 2019, the state began to significantly ramp up its PFAS regulation and research. Spurred by NRDC report, California senator proposes state ban on PFAS California state Sen.

Packaging 40

Packaging Regulations Production Compliance 40

Drug Discovery World

JULY 11, 2022

The global cell and gene therapy (CGT) market reached a value of ~$4 billion in 2020 and is expected to grow to ~$34 billion by 2030 1. Complexities arise while trying to establish a standard, cost-efficient, and expert process for research and manufacturing. 1: TBRC Business Research PVTLTD. TBRCBusiness Research PVT LTD.

Therapies 130

Therapies Clinical Trials Production Trials 130

Drug Discovery World

FEBRUARY 10, 2023

Sweden’s place in the market Scandinavia is home to some of the strongest research and development hubs, with highly respected academic institutes that are helping drive the sector forward. Sweden remains Scandinavia’s powerhouse market for pharmaceutical research and development.

Science 130

Science Drugs Pharmaceutical Companies Pharmaceuticals 130